Moclobemide in social phobia. A double-blind, placebo-controlled clinical study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 2, 1997, Pages 71-80

  Burrows, G ^a   Evans, L ^b   Baumhackl, U ^c   Hebenstreit, H ^d   Katschnig, H ^e,ae   Schony W ^f   Scholz, H ^g   Wilmotte, J ^h   Campos, J ⁱ   Costa, D ^j   Nardi, A ^k   Versiani, M ^k   Da Silva, A ⁱ   Bowen, D L R ^l   Bradwejn, J ^m   Johnston, D ⁿ   Plamondon, J ^o   Stein, M ^p   Swinson, R ^q   Chneiweiss, L ^r   Bellaire, W ^d   Osterheider, M ^s   Sonntag, R ^d   Cookson, J ^t   Freeman, C ^u   Hirsch, S ^v   Mullin, J ^w   Murray, R ^x   Nutt, D ^y   Petursson H ^z   O'Donoghue, F ^aa   Min, J ^ab   Allgulander, C ^ac   Andersch, S ^ad   Realini, R ^d   Siegel, J L ^d   Buller, R ^d   more..

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Allgemeines Oeffentliches Krankhs   (Austria)

^d Psychiat Universitätsklinik ^*

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f KEPLER UNIVERSITY HOSPITAL   (Austria)

^g Allgemeines Oeffentliches L   (Austria)

^h Hôpital Vincent van Gogh   (Belgium)

ⁱ FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^j Secretary of Health of the Minas Gerais State   (Brazil)

^k FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^l ROYAL UNIVERSITY HOSPITAL   (Canada)

^m ST MARY S HOSPITAL   (Canada)

ⁿ Calgary General Hospital   (Canada)

^o LAVAL UNIVERSITY   (Canada)

^p ST BONIFACE GENERAL HOSPITAL   (Canada)

^q CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^r Stress and Anxiety French Institute   (Canada)

^s UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^t ROYAL LONDON HOSPITAL   (United Kingdom)

^u Royal Edinburg Hospital   (Germany)

^v IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^w De la Pole Hospital   (United Kingdom)

^x KING'S COLLEGE LONDON   (United Kingdom)

^y Dept Anat Sch Med Sci U   (United Kingdom)

^z Borgarspitalinn   (United Kingdom)

^aa ST PATRICK S HOSPITAL   (Ireland)

^ab CENTRAL MILITARY HOSPITAL   (Netherlands)

^ac KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ad Lillhagens Sjukhus   (Sweden)

^ae UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Dose response; Double blind clinical study; Moclobemide; Placebo; Social phobia

Indexed keywords

MOCLOBEMIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; STATISTICAL ANALYSIS;

EID: 8244233845     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02900196     Document Type: Article

References (37)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). American Psychiatric Association, Washington DC
2. Amies PL, Gelder MG, Shaw PM (1983) Social phobia: a comparative clinical study. Br J Psychiatry 142:174-179
3. Bisserbe J-C, Lépine J-P, GRP Group (1994) Moclobemide in social phobia: a pilot open study. Clin Neuropharmacol 17:88-94
4. Davidson JRT, Potts N, Richichi E, Krishnan R, Ford SM, Smith R, Wilson WH (1993a) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428
5. Davidson JRT, Hughes DL, George LK, Blazer DG (1993b) The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 23:709-718
6. Fahlén T, Humble M, Koczkas C, Nilsson HL (1992) Social phobia and its treatment with brofaromine. Efficacy regarding social phobia symptoms and personality traits. Clin Neuropharmacol 15:64B
7. First M, Spitzer RL, Williams JBW, Gibbon M (1995) Structured Clinical Interview for DSM-IV - Patient Edition (SCIP-P). American Psychiatric Press, Washington DC
8. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia. Arch Gen Psychiatry 48:938-945
9. Gelernter CS, Stein MB, Tancer ME, Uhde TW (1992) An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder. J Clin Psychiatry 53:23-27
10. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, While K, Sikes C (1995) Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 52:289-295
11. Guy W (1976) Early Clinical Drug Evaluation Unit (ECDEU) assessment manual. US Department of Health, Education and Welfare, Washington DC, pp 217-222
12. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
13. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC (1995) Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 152: 1368-1371
14. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8-19
15. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF (1985) Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatry 42:729-736
16. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A (1986) Phenelzine in social phobia. J Clin Psychopharmacol 6:93-98
17. Liebowitz MR (1987) Social phobia. Modern problems in pharmacopsychiatry 22:141-173
18. Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin AP, Sandberg D, Hollander E, Papp L, Goetz D (1988) Pharmacotherapy of social phobia: an interim report of a placebo controlled comparison of phenelzine and atenolol. J Clin Psychiatry 49:252-257
19. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R, Klein DF (1992) Phenelzine vs atenolol in social phobia: a placebo controlled comparison. Arch Gen Psychiatry 49:290-300
20. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC (1996) Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159-168
21. Manuzza S, Schneier FR, Chapman TF, Liebowitz MR, Klein DF, Fyer AJ (1995) Generalized social phobia: reliability and validity. Reference for social phobia subtype. Arch Gen Psychiatry 52:230-237
22. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
23. Myers JK, Weissman MM, Tischler GL, Holzer CE, Leaf PJ, Orvaschel H, Anthony JL, Boyd JH, Burke JD, Kramer M, Stoltzman R (1984) Six month prevalence of psychiatric disorders in three countries. Arch Gen Psychiatry 41:959-967
24. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992) Social phobia. Comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 49:282-288
25. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, Street L, Del Bene D, Liebowitz MR (1993) Functional impairment in social phobia. J Clin Psychiatry 55:322-331
26. Sheehan DV (1983) The anxiety disease and how to overcome it. Schribner, New York, pp 148-149
27. Solyom L, Ledwidge B, Solyom C (1986) Delineating social phobia. Br J Psychiatry 149:464-470
28. Spitzer RL, Williams JBW, Gibbon M, First M (1990) Structured Clinical Interview for DSM-III-R - Patient Edition (SCIP-P). American Psychiatric Press, Washington DC
29. Stabl M, Biziere K, Schmid-Burgk W, Amrein R (1989) Review of comparative clinical trials: moclobemide vs tricyclic antidepressants and vs placebo in depressive states. J Neural Transm 45:77-90
30. Stein MB (1996) How shy is too shy? Lancet 347:1131-1132
31. Swinson RP, Cox BJ, Woszczyna CB (1992) Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Can Med Assoc J 147:878-883
32. Van Vliet IM, Boer JA den, Westenberg HGM (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 2:21-29
33. Van Vliet IM, Boer JA den, Westenherg HGM (1994) A novel psychopharmacological approach to social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology 115:128-134
34. Versiani M (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360
35. Versiani M, Mundim FD, Nardi AE, Liebowitz MR (1988) Tranylcypromine in social phobia. J Clin Psychopharmacol 8:279-283
36. Versiani M, Oggero U, Alterwain P, Capponi R, Dajas F, Heinze-Martin G, Marquez CA, Poleo MA, Rivero-Almanzor LE, Rossel L, Schmid-Burgk W, Ucha Udabe R (1989) A double-blind comparative trial of moclobemide vs imipramine and placebo in major depressive episodes. Br J Psychiatry 155:72-77
37. World Health Organisation (1992) Mental health and behavioral disorders (including disorders of psychological development). In: International classification of diseases, 10th rev. World Health Organisation, Geneva, Switzerland